scholarly journals Clinical Diagnosis and Management of Hypertension Compared With the Joint National Committee 8 Panelists' Recommendations

2015 ◽  
Vol 38 (6) ◽  
pp. 333-343 ◽  
Author(s):  
David Snipelisky ◽  
Oral Waldo ◽  
M. Caroline Burton
Author(s):  
Bhargavi M ◽  
Shilpa PN ◽  
K. Chaithanya

In worldwide 25% of population is suffering with Hypertension. As it is an instrumental disease, asymptomatic in nature, it was named as Silent killer. The causative factors of Essential hypertension were Genetic predisposition and environmental factors but these factors are triggered by stress hence it comes under stress related psycho-somatic disorder. In Hypertensive patients, Decrease in 5mm of Hg in SBP and DBP results in decrease in cardiovascular risk, stroke which decreases mortality rate worldwide. The management aspect of modern medical science remains symptomatic with troublesome side effects. The Joint National Committee (JNC 8) guideline advise higher blood pressure goals, less use of several types of antihypertensive medications and suggests lifestyle modification and relaxation are the best initial therapy. In Ayurveda, Shirodhara is one of the panchakarma therapy meant for relaxation and stress reducing procedure mentioned in Dharakalpaas a preventive and curative treatment for many stress related disorders. So, Present study is planned as “A Comparative clinical evaluation of Shirodhara with Sukhos̩n̩ajala, Tila tailam and Brahmitailamin the management of mild to moderate essential hypertension”was selected. This paper is going to describe about conclusion drawn from the study i.e. effect of three types of dhara on Objective parameters SBP, DBP, PP, and MAP.


Hypertension ◽  
2003 ◽  
Vol 42 (6) ◽  
pp. 1206-1252 ◽  
Author(s):  
Aram V. Chobanian ◽  
George L. Bakris ◽  
Henry R. Black ◽  
William C. Cushman ◽  
Lee A. Green ◽  
...  

2002 ◽  
Vol 15 (2) ◽  
pp. 132-147 ◽  
Author(s):  
Maria Olganê Dantas SABRY ◽  
Helena Alves de Carvalho SAMPAIO ◽  
Marcelo Gurgel Carlos da SILVA

O objetivo deste estudo foi identificar a prevalência de hipertensão arterial e obesidade, bem como sua inter-relação em funcionários de uma instituição de ensino superior da cidade de Fortaleza, Ceará. Foram entrevistados e avaliados, a partir de dados antropométricos e de pressão arterial, 317 funcionários. Para a aferição e classificação da pressão arterial, foram adotados os critérios do III Consenso Brasileiro de Hipertensão Arterial de 1998 e do Joint National Committee de 1997. Foi utilizado o Índice de Massa Corporal para a classificação nutricional, segundo critérios da Organização Mundial da Saúde de 1995. Encontrou-se uma prevalência de hipertensão arterial de 25,6% e de excesso de peso de 59,9%, ambas significativamente mais prevalentes no sexo masculino (p<0,05). A obesidade foi fator de risco para hipertensão arterial no grupo estudado (OR 7,53; IC95 3,08-18,92; p= 0,00). Os resultados encontrados enquadram a comunidade pesquisada como grupo alvo de ações de saúde destinadas ao controle das doenças crônicas.


2014 ◽  
Vol 6 (1) ◽  
pp. 35-36
Author(s):  
K. Kaitanidis ◽  
M. Doumas ◽  
K. Tziomalos ◽  
V. G. Athyros

Full Text Available.


2021 ◽  
Vol 8 ◽  
Author(s):  
Bo Liang ◽  
Rui Li ◽  
Jia-Yue Bai ◽  
Ning Gu

Heart failure is a clinical syndrome, resulting in increased intracardiac pressure and/or decreased cardiac output under rest or stress. In acute decompensated heart failure, volume assessment is essential for clinical diagnosis and management. More and more evidence shows the advantages of bioimpedance vector analysis in this issue. Here, we critically present a brief review of bioimpedance vector analysis in the prediction and management of heart failure to give a reference to clinical physicians and guideline makers.


Author(s):  
RANJODH JEET SINGH

Aim and Objectives: The aim of the study was to compare the efficacy of Atenolol and Olmesartan in Stage-1 hypertension (HTN), and the adverse effect profile of Atenolol and Olmesartan in Stage-1 HTN. Methods: A prospective, randomized, open, and parallel study was carried out in 100 patients attending the outpatient department of General Medicine Department MMIMSR, Mullana, Ambala, India with Stage -1 HTN according to joint national committee VII. The patients were randomly divided into two groups to receive Tab. Atenolol 50 mg od (Group A, n=50) and Tab. Olmesartan medoxomil 20 mg (Group B, n=50) od for a total period of 12 weeks with regular follow up every 2 weeks from the baseline. At each visit, blood pressure (BP), heart rate, and adverse effects were evaluated. Laboratory investigations were carried out at baseline and end of the study period. p<0.005 was considered statistically significant. Results: Atenolol and Olmesartan medoxomil both significantly reduce BP and heart rate (p<0.005). Olmesartan medoxomil is more efficacious in reducing BP. Conclusion: Olmesartan medoxomil is a better choice for Stage -1 HTN between the two drugs as it leads to a greater decrement in BP.


2021 ◽  
Author(s):  
Sadaf G. Sepanlou ◽  
Farid Najafi ◽  
Hossein Poustchi ◽  
Mahboubeh Parsaeian ◽  
Ali Ahmadi ◽  
...  

Abstract In this cross-sectional population-based study, we used the baseline data of the Prospective Epidemiologic Research Studies in IrAN (PERSIAN) cohort study collected in Iran from 2014 to 2020. The main outcomes were the prevalence of hypertension and proportion of awareness, treatment, and control based on the 2017 ACC/AHA guideline compared to the seventh report of the Joint National Committee (JNC7). Of the total of 163770 participants, aged 35 to 70 years, 55.2% were female. The sex-age standardized prevalence of hypertension was 22.3% (95% CI: 20.6-24.1) based on the JNC7 guideline and 36.5% (31.1-41.8) based on the ACC/AHA guideline. A total of 24312 participants [14.1% [10.1, 18.1)] were newly diagnosed based on the ACC/AHA guideline. Compared to adults diagnosed with hypertension based on the JNC7 guideline, the newly diagnosed participants were mainly young literate males who had low levels of risk factors and were free from conventional comorbidities of hypertension. About 30.7% (25.9, 35.4) of them (4.3% of the entire population) were eligible for pharmacologic intervention based on the ACC/AHA guideline. Implementation of the new guideline may impose additional burden on health systems. However, early detection and management of elevated blood pressure may reduce the ultimate burden of hypertension in Iran.


1998 ◽  
Vol 37 (3) ◽  
pp. 305-306 ◽  
Author(s):  
Anton Niedermayr ◽  
Kamran Gharehbaghi ◽  
Barbara Pacher ◽  
Monika Wirth ◽  
Werner Grünberger

Sign in / Sign up

Export Citation Format

Share Document